{"nct_id":"NCT01080131","title":"Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.","status":"COMPLETED","status_verified_date":"2013-04","start_date":"2010-03","start_date_type":null,"primary_completion_date":"2010-11","primary_completion_date_type":"ACTUAL","completion_date":"2011-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}